Air pollution and cardiovascular disease: Increased risk for women with diabetes

November 25, 2015

Air pollution is a major risk factor for cardiovascular disease, and some people may be more susceptible to its effects than others. Investigators from Brigham and Women's Hospital (BWH) and Harvard T. H. Chan School of Public Health used data from a nationwide study of nurses to look for factors that made people more vulnerable to the effects of long-term air pollution exposure. One factor in particular stood out to the researchers: type 2 diabetes. The team reports its findings in a paper published November 25 in the Journal of the American Heart Association Report.

"We didn't expect diabetes to be the strongest factor in determining susceptibility," said study lead author Jaime E. Hart, Sc.D., an epidemiologist in the Channing Division of Network Medicine at BWH and the Department of Environmental Health at Harvard Chan School. "We looked at age, family history of cardiovascular disease, weight, smoking status and region of the country but diabetes was the most consistent across diseases and across different size fractions of particulate matter."

The research team explored data from more than 100,000 participants in the Nurses' Health Study (NHS), looking at rates of cardiovascular disease, specifically incidence of coronary heart disease and stroke. They assessed long-term exposure to three different sizes of particulate matter air pollution from 1989 to 2006.

Among women with diabetes, increased risk was statistically significant for all cardiovascular outcomes measured and across all sizes of particulate matter. (For the general population of women in the study, the researchers found that long-term exposure to air pollution led to small, but not statistically significant, increases in risk of cardiovascular events.)

The team found that for each increase of 10 micrograms per cubic meter of air pollution (the equivalent of the difference in air quality between a city like Los Angeles, CA and a city like St. Louis, MO), a woman's risk of cardiovascular disease increased by 44 percent if she had type 2 diabetes. The team found that these effects were greater in women over the age of 70, obese, and/or living in the northeast or south.

The researchers note that exposure data may be less accurate for earlier time points in their study due to fewer air pollution monitoring stations before 1999, and that these results are based on participants' residential addresses, which may not necessarily be where they spent most of their time. In addition, since the NHS is predominantly made up middle-aged to elderly white women, further studies will be needed to determine if these patterns are also seen in men and in racially and socioeconomically diverse populations.

"Continuing to identify subgroups that are most susceptible to the effects of air pollution is critically important for setting pollution standards and regulations so that those who are most vulnerable can be protected," said Hart. "Individuals, especially those who may be at greater risk, can also take precautions to help limit their exposure. And we would always recommend that individuals don't smoke, eat a healthy diet, and get regular exercise to reduce their risk for cardiovascular disease." Senior author Francine Laden, ScD, Professor in the Departments of Environmental Health and Epidemiology at Harvard Chan School, added, "We are currently working to determine if individuals who make healthier lifestyle choices are less susceptible to the adverse impacts of air pollution, and to determine if similar patterns of susceptibility are seen in men."
-end-
Other researchers who contributed to this work include Robin C. Puett, Ph.D.; Kathryn M. Rexrode, M.D., M.P.H.; Christine M. Albert, M.D., M.P.H.; and Francine Laden, Sc.D. This work was supported by the National Institutes of Health (grants R01 ES017017, UM1 CA186107, R01 HL034594, and R01 HL088521) and American Heart Association Science (Development Grant #13SDG14580030).

Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 4.2 million annual patient visits, nearly 46,000 inpatient stays and employs nearly 16,000 people. The Brigham's medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Brigham Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, more than 1,000 physician-investigators and renowned biomedical scientists and faculty supported by nearly $600 million in funding. For the last 25 years, BWH ranked second in research funding from the National Institutes of Health (NIH) among independent hospitals. BWH continually pushes the boundaries of medicine, including building on its legacy in transplantation by performing a partial face transplant in 2009 and the nation's first full face transplant in 2011. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative as well as the TIMI Study Group, one of the premier cardiovascular clinical trials groups. For more information, resources and to follow us on social media, please visit BWH's online newsroom.

Harvard T.H. Chan School of Public Health brings together dedicated experts from many disciplines to educate new generations of global health leaders and produce powerful ideas that improve the lives and health of people everywhere. As a community of leading scientists, educators, and students, we work together to take innovative ideas from the laboratory to people's lives--not only making scientific breakthroughs, but also working to change individual behaviors, public policies, and health care practices. Each year, more than 400 faculty members at Harvard Chan School teach 1,000-plus full-time students from around the world and train thousands more through online and executive education courses. Founded in 1913 as the Harvard-MIT School of Health Officers, the School is recognized as America's oldest professional training program in public health.

Contact: Haley Bridger
Brigham and Women's Hospital
617-525-6383, hbridger@partners.org

Contact: Todd Datz
Harvard T.H. Chan School of Public Health
617-432-8413, tdatz@hsph.harvard.edu

Brigham and Women's Hospital

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.